Paul Tudor Jones's TERN Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 73,246 shares of Terns Pharmaceuticals, Inc. (TERN) worth $2.96 M, representing 0.01% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 4 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in TERN for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 73,246 shares. Largest reduction occurred in Q4 2024, reducing 10,263 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Terns Pharmaceuticals (TERN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Terns Pharmaceuticals (TERN) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +73,246 | New Buy | 73,246 | $40.40 |
| Q4 2024 | -10,263 | Sold Out | 0 | $0.00 |
| Q3 2024 | -5,490 | Reduce 34.85% | 10,263 | $8.34 |
| Q2 2024 | +15,753 | New Buy | 15,753 | $6.81 |
Paul Tudor Jones's Terns Pharmaceuticals Investment FAQs
Paul Tudor Jones first purchased Terns Pharmaceuticals, Inc. (TERN) in Q2 2024, acquiring 15,753 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Terns Pharmaceuticals, Inc. (TERN) for 4 quarters since Q2 2024.
Paul Tudor Jones's largest addition to Terns Pharmaceuticals, Inc. (TERN) was in Q4 2025, adding 73,246 shares worth $2.96 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 73,246 shares of Terns Pharmaceuticals, Inc. (TERN), valued at approximately $2.96 M.
As of the Q4 2025 filing, Terns Pharmaceuticals, Inc. (TERN) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Terns Pharmaceuticals, Inc. (TERN) was 73,246 shares, as reported at the end of Q4 2025.